Kojima, Tadahiro
Kurachi, Kiyotaka
Tatsuta, Kyota
Sugiyama, Kosuke
Akai, Toshiya
Suzuki, Katsunori
Torii, Kakeru
Sakata, Mayu
Morita, Yoshifumi
Kikuchi, Hirotoshi
Hiramatsu, Yoshihiro
Fukazawa, Atsuko
Takeuchi, Hiroya
Article History
Received: 25 October 2022
Accepted: 3 February 2023
First Online: 13 February 2023
Declarations
:
: The study conformed to the Pharmaceutical Affairs Law of Japan and was conducted in accordance with the Good Clinical Practice guidelines. Written informed consent was obtained from the patient.
: Informed consent was obtained from the patient for the publication of this case report.
: The authors declare that they have no competing interests.